tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Paul Choi, 33 are a SELL (16.67%), 69 are a HOLD (34.85%), 96 are a BUY (48.48%).
Analyst Paul Choi, carries an average stock price target met ratio of 57.93% that have a potential upside of 30.55% achieved within 172 days. Previously, Paul Choi worked at GOLDMAN SACHS, BARCLAYS.
Paul Choi’s has documented 376 price targets and ratings displayed on 51 stocks. The coverage was on Healthcare, Pharmaceuticals, Technology sectors.
Most recent stock forecast was given on RGNX, Regenxbio at 10-Feb-2026.
Analyst best performing recommendations are on SBTX (SILVERBACK THERAPEUTICS ).
The best stock recommendation documented was for SBTX (SILVERBACK THERAPEUTICS ) at 12/29/2020. The price target of $43 was fulfilled within 2 days with a profit of $6 (16.22%) receiving and performance score of 81.08.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$3
$1.79 (147.93%)
$3
1 years 10 months 4 days ago
(26-Sep-2024)
0/4 (0%)
$2.42 (417.24%)
Hold
$7
2 years 1 months 10 days ago
(20-Jun-2024)
1/3 (33.33%)
$0.45 (6.87%)
57
Sell
$1
$-0.21 (-17.36%)
$1.5
2 years 6 months 13 days ago
(17-Jan-2024)
6/6 (100%)
$-0.02 (-1.96%)
278
Buy
2 years 7 months 12 days ago
(18-Dec-2023)
1/1 (100%)
$32.69 (83.16%)
358
Buy
$9
$7.79 (643.80%)
3 years 2 months 19 days ago
(11-May-2023)
2/4 (50%)
$4.84 (116.35%)
178
Which stock is Paul Choi is most bullish on?
What Year was the first public recommendation made by Paul Choi?
